Dunton Alan W's Form 4 filing
CorMedix Inc. (CRMD) · filed Dec 18, 2023
- Accession no.
- 0000929638-23-003434
- Filed
- Dec 18, 2023
- Trade date
- Dec 14-15, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $20.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dunton Alan WCIK 0001304773 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | Common Stock | PPurchaseAcquired | +3,000 | $3.45 | +$10,350 | 12,250 | Direct | |
| Dec 15, 2023 | Common Stock | PPurchaseAcquired | +3,000 | $3.30 | +$9,900 | 15,250 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.